@article{Anderson_M-2021_32841,
title = {LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19},
author = {Anderson, M. and Pitchforth, E. and Asaria, M. and Brayne, C. and Casadei, B. and Charlesworth, A. and Coulter, A. and Franklin, B. and Donaldson, C. and Drummond, M. and Dunnell, K. and Foster, M. and Hussey, R. and Johnson, P. and Johnston-Webber, C. and Knapp, M. and Lavery, G. and Longley, M. and Clark, J. and Majeed, A. and McKee, M. and Newton, J. and O'Neill, C. and Raine, R. and Richards, M. and Sheikh, A. and Smith, P. and Street, A. and Taylor, D. and Watt, R. and Whyte, M. and Woods, M. and McGuire, A. and Mossialos, E.},
month = {may},
year = {2021},
abstract = {The UK has recorded one of the highest death rates associated with COVID-19 globally, whether measured as deaths that are directly attributable to COVID-19 or by excess mortality. The reasons for this high rate are complex and not yet fully understood, but elements of the UK Government response have been criticised, including delayed implementation of physical distancing measures, poor coordination with local authorities and public health teams, a dysfunctional track and trace system, and an absence of consultation with devolved nations. The role of the National Health Service (NHS) and relevant national executive agencies in relation to testing capacity, availability of personal protective equipment (PPE), the cancellation and postponement of many aspects of routine care, and decisions around discharge from hospital to care homes should also be critically examined. Conversely, aspects of the response by the NHS and relevant national executive agencies deserve recognition. In only a few weeks, capacity for critical care was massively expanded, many thousands of staff were reallocated, and services were reorganised to reduce transmission of SARS-CoV-2. The NHS also collaborated with academic institutions to share knowledge about clinical characteristics of the disease and to establish world-leading clinical trials on vaccines and treatments.},
pages = {1915-1978},
volume = {397},
issue = {10288},
journal = {The Lancet},
publisher = {Elsevier},
url = {https://doi.org/10.1016/S0140-6736(21)00232-4},
}
